Discontinuation report OMNIPAQUE 240
Report ID | 182760 |
Drug Identification Number | 02172739 |
Brand name | OMNIPAQUE 240 |
Common or Proper name | iohexol injection USP |
Company Name | GE HEALTHCARE CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | IOHEXOL |
Strength(s) | 518MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVASCULAR SUBARACHNOIDAL INTRAVASCULAR SUBARACHNOIDAL |
Packaging size | 200 mL |
ATC code | V08AB |
ATC description | X-RAY CONTRAST MEDIA, IODINATED |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2023-03-17 |
Actual discontinuation date | 2023-03-17 |
Remaining supply date | 2023-03-17 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1919 MINNESOTA COURT MISSISSAUGA, ONTARIO CANADA L5N 0C9 |
Company contact information | 800-387-7146 canadainfo@gehealthcare.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v13 | 2023-03-18 | English | Compare |
v12 | 2023-03-17 | French | Compare |
v11 | 2023-03-17 | English | Compare |
v10 | 2023-03-14 | French | Compare |
v9 | 2023-03-14 | English | Compare |
v8 | 2023-03-06 | French | Compare |
v7 | 2023-03-06 | English | Compare |
v6 | 2023-02-24 | French | Compare |
v5 | 2023-02-24 | English | Compare |
v4 | 2023-02-24 | French | Compare |
v3 | 2023-02-24 | English | Compare |
v2 | 2023-01-31 | French | Compare |
v1 | 2023-01-31 | English | Compare |
Showing 1 to 13 of 13